Inventor · disambiguated record
Oliver Claude Venn
Also filed as: VENN III OLIVER CLAUDE · VENN OLIVER · VENN OLIVER CLAUDE
12 granted patents·40 pending applications·36 citations·filing 2009–2025
88Inventor score
Top patents by PatentIndex Score
52 records- 0195US11795513B2Methylation markers and targeted methylation probe panelGRAIL LLC·Filed 2022·Granted Oct 24, 2023·5 cites·19 claims
- 0295US11725251B2Methylation markers and targeted methylation probe panelGRAIL LLC·Filed 2022·Granted Aug 15, 2023·6 cites·19 claims
- 0395US11685958B2Methylation markers and targeted methylation probe panelGRAIL LLC·Filed 2021·Granted Jun 27, 2023·5 cites·23 claims
- 0495US11410750B2Methylation markers and targeted methylation probe panelGRAIL LLC·Filed 2021·Granted Aug 9, 2022·10 cites·28 claims
- 0593US12410482B2Methylation markers and targeted methylation probe panelGRAIL INC·Filed 2023·Granted Sep 9, 2025·1 cites·19 claims
- 0691US12024750B2Methylation markers and targeted methylation probe panelGRAIL LLC·Filed 2020·Granted Jul 2, 2024·5 cites·21 claims
- 0780US2024331873A1Variant based disease diagnostics and trackingGRAIL LLC·Filed 2024·Application pending·0 cites
- 0877US12435375B2Methylation markers and targeted methylation probe panelGRAIL INC·Filed 2020·Granted Oct 7, 2025·1 cites·26 claims
- 0976US11581062B2Systems and methods for classifying patients with respect to multiple cancer classesGRAIL LLC·Filed 2019·Granted Feb 14, 2023·2 cites·50 claims
- 1073US2022333212A1Methods of identifying somatic mutational signatures for early cancer detectionGRAIL INC·Filed 2022·Application pending·0 cites
- 1173US2024412821A1Methylation-based biological sex predictionGRAIL LLC·Filed 2024·Application pending·0 cites
- 1272US12234514B2Source of origin deconvolution based on methylation fragments in cell-free DNA samplesGRAIL LLC·Filed 2019·Granted Feb 25, 2025·1 cites·17 claims
- 1370US12191000B2Systems and methods for classifying patients with respect to multiple cancer classesGRAIL LLC·Filed 2023·Granted Jan 7, 2025·0 cites·27 claims
- 1469US2025349431A1Multi-Assay Prediction Model for Cancer DetectionGRAIL INC·Filed 2025·Application pending·0 cites
- 1568US2025037876A1Systems and methods for developing and utilizing a hematologic prognostic classifierGRAIL LLC·Filed 2024·Application pending·0 cites
- 1668US2024312564A1White blood cell contamination detectionGRAIL LLC·Filed 2024·Application pending·0 cites
- 1768US2022119890A1Detecting cancer, cancer tissue of origin, and/or a cancer cell typeGRAIL LLC·Filed 2021·Application pending·0 cites
- 1868US2022090207A1Detecting cancer, cancer tissue of origin, and/or a cancer cell typeGRAIL LLC·Filed 2021·Application pending·0 cites
- 1967US2025342964A1Cancer Classification with Tissue of Origin ThresholdingGRAIL INC·Filed 2025·Application pending·0 cites
- 2066US2025297325A1Source of origin deconvolution based on methylation fragments in cell-free dna samplesGRAIL INC·Filed 2025·Application pending·0 cites
- 2166US2024170099A1Methylation-based age prediction as feature for cancer classificationGRAIL LLC·Filed 2023·Application pending·0 cites
- 2265US2024233872A9Component mixture model for tissue identification in dna samplesGRAIL LLC·Filed 2023·Application pending·0 cites
- 2365US2024321389A1Models for Targeted SequencingGRAIL LLC·Filed 2024·Application pending·0 cites
- 2463US2024117435A1Systems and methods for performing methylation-based risk stratification for myelodysplastic syndromesGRAIL LLC·Filed 2023·Application pending·0 cites
- 2562US2024296920A1Redacting cell-free dna from test samples for classification by a mixture modelGRAIL LLC·Filed 2024·Application pending·0 cites
- 2662US2022064737A1Detecting cancer, cancer tissue of origin, and/or a cancer cell typeGRAIL LLC·Filed 2021·Application pending·0 cites
- 2762US2022098672A1Detecting cancer, cancer tissue of origin, and/or a cancer cell typeGRAIL LLC·Filed 2021·Application pending·0 cites
- 2860US2023272486A1Tumor fraction estimation using methylation variantsGRAIL LLC·Filed 2023·Application pending·0 cites
- 2959US2024038335A1Systems and methods for detecting disease subtypesGRAIL LLC·Filed 2023·Application pending·0 cites
- 3059US2021395841A1Detection and classification of human papillomavirus associated cancersGRAIL INC·Filed 2021·Application pending·0 cites
- 3159US2010217642A1System and method for single-action energy resource scheduling and participation in energy-related securitiesCRUBTREE JASON·Filed 2009·Application pending·0 cites
- 3258US2021166813A1Systems and methods for evaluating longitudinal biological feature dataGRAIL INC·Filed 2020·Application pending·0 cites
- 3358US2024161867A1Optimization of model-based featurization and classificationGRAIL LLC·Filed 2023·Application pending·0 cites
- 3457US2022333209A1Conditional tissue of origin return for localization accuracyGRAIL LLC·Filed 2022·Application pending·0 cites
- 3555US2023057154A1Somatic variant cooccurrence with abnormally methylated fragmentsGRAIL LLC·Filed 2022·Application pending·0 cites
- 3655US2018203974A1Methods of identifying somatic mutational signatures for early cancer detectionGRAIL INC·Filed 2017·Application pending·0 cites
- 3753US12497662B2Systems and methods for tumor fraction estimation from small variantsGRAIL INC·Filed 2020·Granted Dec 16, 2025·0 cites·22 claims
- 3853US2020239964A1Anomalous fragment detection and classificationGRAIL INC·Filed 2019·Application pending·0 cites
- 3953US2017213008A1Variant based disease diagnostics and trackingGRAIL INC·Filed 2017·Application pending·0 cites
- 4052US2020385813A1Systems and methods for estimating cell source fractions using methylation informationGRAIL INC·Filed 2019·Application pending·0 cites
- 4152US2021104297A1Systems and methods for determining tumor fraction in cell-free nucleic acidGRAIL INC·Filed 2019·Application pending·0 cites
- 4252US2019355438A1Inferring selection in white blood cell matched cell-free dna variants and/or in rna variantsGRAIL INC·Filed 2019·Application pending·0 cites
- 4350US2021327534A1Cancer classification using patch convolutional neural networksNICULA VIRGIL·Filed 2020·Application pending·0 cites
- 4450US2021285042A1Systems and methods for calling variants using methylation sequencing dataGRAIL INC·Filed 2021·Application pending·0 cites
- 4549US2021115520A1Systems and methods for using pathogen nucleic acid load to determine whether a subject has a cancer conditionGRAIL INC·Filed 2019·Application pending·0 cites
- 4648US11961589B2Models for targeted sequencingGRAIL INC·Filed 2018·Granted Apr 16, 2024·0 cites·28 claims
- 4748US2010218108A1System and method for trading complex energy securitiesCRABTREE JASON·Filed 2010·Application pending·0 cites
- 4846US2021125686A1Cancer classification with tissue of origin thresholdingGRAIL INC·Filed 2020·Application pending·0 cites
- 4946US2019316209A1Multi-Assay Prediction Model for Cancer DetectionGRAIL INC·Filed 2019·Application pending·0 cites
- 5043US2019338349A1Methods and systems for high fidelity sequencingGRAIL INC·Filed 2017·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Oliver Claude Venn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →